Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gamma-irradiated BCG vaccination for trained innate immunity
NL-OMON38603Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of gamma-irradiated bacillus calmette-guérin vaccine in immunomodulation, sponsored by Radboud University Medical Center. Primary endpoint: Change in cytokine production after vaccination. Started Jan 2014; status: active, not recruiting.
02
Drugs
gamma-irradiated bacillus calmette-guérin vaccine
03
Conditions
immunomodulation
Beyond the preview
Go deeper on NL-OMON38603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38603.